EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real‐world evidence of systemic treatment practices for biliary tract cancer in Japan: Results of a database study

Makoto Ueno, Sachiyo Shirakawa, Jumpei Tokumaru, Mizue Ogi, Kenichiro Nishida, Takehiro Hirai, Kenta Shinozaki, Yoko Hamada, Hiroshi Kitagawa, Akihiko Horiguchi

Journal of Hepato-Biliary-Pancreatic Sciences · 2024

DOI: 10.1002/jhbp.1418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2024. Verfasst von Makoto Ueno und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Yokohama, Japan. Hauptthemen laut MEDLINE: Biliary Tract Neoplasms, Databases, Factual. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca K.K..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To describe the real‐world treatment patterns of systemic therapies for biliary tract cancer (BTC) and to examine the frequency and management of biliary infection in Japan.

Methods

Patients diagnosed with BTC and prescribed systemic therapy between January 2011 and September 2020 were retrieved from the Japanese Medical Data Vision database. The look‐back period was set to 5 years. Patient characteristics, treatment patterns, and biliary infection‐induced treatment interruption were analyzed.

Results

The full analysis set comprised 22 742 patients with a mean age of 71.0 years and 61.6% were male. The most common BTC type was extrahepatic cholangiocarcinoma (44.6%). The three most common first‐line regimens were S‐1 monotherapy (33.0%), gemcitabine+cisplatin (32.5%), and gemcitabine monotherapy (18.7%) over the entire observation period (January 2011–September 2021). Patients who received monotherapies tended to be older. Biliary infection‐induced treatment interruption occurred in 29.5% of patients, with a median time to onset of 64.0 (interquartile range 29.0–145.0) days. The median duration of intravenous antibiotics was 12.0 (interquartile range 4.0–92.0) days.

Conclusions

These results demonstrated potential challenges of BTC in Japanese clinical practice particularly use of multiple regimens, commonly monotherapies, which are not recommended as first‐line treatment, and the management of biliary infections during systemic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biliary Tract NeoplasmsDatabases, FactualHumansMaleFemaleAgedJapanMiddle AgedDeoxycytidineGemcitabineTegafurRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsDrug CombinationsCisplatinOxonic AcidPractice Patterns, Physicians'

Stichwörter der Autor:innen

antibioticschemotherapycholangiocarcinomacholangitisdrug therapy

Substanzen

DeoxycytidineGemcitabineTegafurDrug CombinationsCisplatinOxonic AcidS 1 (combination)

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Yokohama, Japan.
  • Oncology Medical, AstraZeneca K.K., Osaka, Japan.
  • Evidence and Observational Research, Medical, AstraZeneca K.K., Osaka, Japan.
  • Department of Gastroenterological Surgery, Fujita Health University School of Medicine, Nagoya, Japan.

Förderung

  • AstraZeneca K.K.

Zitieren

APA

Ueno, M., Shirakawa, S., Tokumaru, J., Ogi, M., Nishida, K., Hirai, T., Shinozaki, K., Hamada, Y., Kitagawa, H., & Horiguchi, A. (2024). Real‐world evidence of systemic treatment practices for biliary tract cancer in Japan: Results of a database study. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.1418

Vancouver

Ueno M, Shirakawa S, Tokumaru J, Ogi M, Nishida K, Hirai T, et al. Real‐world evidence of systemic treatment practices for biliary tract cancer in Japan: Results of a database study. Journal of Hepato-Biliary-Pancreatic Sciences. 2024. doi:10.1002/jhbp.1418

BibTeX
@article{Ueno2024,
  author = {Ueno, Makoto and Shirakawa, Sachiyo and Tokumaru, Jumpei and Ogi, Mizue and Nishida, Kenichiro and Hirai, Takehiro and Shinozaki, Kenta and Hamada, Yoko and Kitagawa, Hiroshi and Horiguchi, Akihiko},
  title = {Real‐world evidence of systemic treatment practices for biliary tract cancer in Japan: Results of a database study},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2024},
  doi = {10.1002/jhbp.1418}
}
Kostenlos starten →